Wyoming Safety Improvement Fund

This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a significant improvement in the translational relevance of animal models or ex vivo systems that will be utilized to facilitate future development of neurotherapeutics. Ideally, models proposed for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Program focused on enabling the exploratory and early stages of drug discovery.

The Community STAND program is a grant initiative from the Denver Urban Renewal Authority designed to support the small businesses, nonprofits and Business Improvement Districts that help anchor Denver’s neighborhoods. Grants range from $10,000 to $50,000. C-STAND supports projects that help community-serving organizations remain anchored in their neighborhoods while strengthening the existing community fabric. Grant funding may be used for a variety of eligible project costs that support stabilization, long-term presence and positive community impact. Supported projects may include physical improvements, equipment purchases, costs associated with securing or owning space and other investments that enhance an organization’s ability to serve its community. DURA is open to creative proposals and encourages applicants to share how their project supports neighborhood stability, preserves community culture and advances the goals of the C-STAND program.

The FY 2026 National Technical Assistance Programs (NTAP) cooperative agreement supports three national organizations to develop and deliver technical assistance (TA) to existing and potential health centers with a focus on: Supporting the delivery of comprehensive, high-quality primary health care; improving chronic disease management, nutrition, and preventive services; improving operational effectiveness, efficiency, and quality; addressing emergent public health needs and priorities; complying with and exceeding Health Center Program and supplemental funding requirements.

The Additive Voucher Program (AVP) provides companies with a matching grant to assist with the acquisition of Additive Manufacturing technology. Eligible companies can apply for a grant up to $20,000 for Additive Manufacturing Hardware, Software, and related third-party integration services. Funding is awarded on a first-come first-served basis. The program is administered by the Connecticut Center for Advanced Technology with funding provided through the Connecticut Department of Economic and Community Development's Manufacturing Innovation Fund.

This Notice of Funding Opportunity (NOFO) encourages grant applications for Animal and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals and associated services, as well as other resources such as informatics tools, reagents, cultures (cells, tissues, and organs) and genetic stocks that serve the biomedical research community in a variety of research areas on a local, regional, and national basis. The goal of projects supported by this NOFO is to provide research resources that facilitate optimization and enhancement of scientific rigor, transparency, and experimental reproducibility of biomedical research. Proposed Animal and Biological Material Resource Centers must have broad application to multiple NIH Institutes or Centers (ICs) to align with the ORIP"s NIH-wide mission (https://orip.nih.gov/about-orip). This funding opportunity is designed to support both continuation of existing resources and to develop new ones when appropriate. Of special interest of the announcement is a requirement of the Center"s close coordination with efforts to develop new approach methodologies (NAMs) that complement traditional animal-based research. These include cell culture, organoids, computational models, and microphysiological systems. Applied Research Component should include studies to generate comparative data to increase applicability of NAMs and promote integration of the most predictive human disease models.